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Abstract
Staphylococcus aureus causes a wide variety of infections including osteomyelitis, endocarditis,
and necrotizing pneumonia. It has been known for decades that S. aureus is auxotrophic for many
amino acids including arginine. However, we discovered that after extended incubation, S. aureus
can be trained to grow in a defined media lacking arginine. We demonstrate here that this delayed
growth is due to the selection of mutations in ahrC, a transcriptional regulator of arginine
biosynthesis. A mutation in ahrC mediates the growth of S. aureus in CDM-R by facilitating the
biosynthesis of arginine via proline. Mutations in putA and argGH halt the growth of the JE2 ahrC
mutant while a mutation in argDCJB did not. In addition, Liquid Chromatography with tandem
mass spectrometry (LC-MS/MS) analysis showed that 13C5-labelled arginine was detected in the
JE2 ahrC mutant when grown in the presence of
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C5-labelled proline and not of13C5-labelled

glutamate further confirming that proline is the precursor of arginine. Furthermore, our
transcriptional analysis results demonstrate that AhrC in S. aureus functions to primarily repress
argGH

and arcB1 allowing for arginine biosynthesis via proline. Although the mechanism of arginine
biosynthesis regulation was shown to be conserved among species, our data demonstrate that AhrC
in S. aureus functions to regulate arginine biosynthesis differently, with the biosynthesis being
mediated through the urea cycle using proline as a precursor instead of the highly conserved and
well-characterized glutamate pathway which was shown to be inactive in-vitro
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1. Chapter 1: Introduction

Staphylococcus aureus is a common cause of community-associated and hospital-acquired
infections. Clinical manifestations can range from skin and soft tissue infections to more severe
conditions such as bacteremia, osteomyelitis, endocarditis, and necrotizing pneumonia[1]. The
ability of S. aureus to infect multiple organ systems was initially attributed to the acquisition of
multiple of virulence factors. However, it was documented that S. aureus has evolved to
metabolically adapt to cause invasive infections. Therefore, to thrive in different environments, S.
aureus must scavenge nutrients and coordinate nitrogen and carbon usage. It has been documented
that glycolysis is essential for S. aureus virulence and tissue invasion[2]. However, within
staphylococcal abscesses, glucose, a preferred carbon source for S. aureus is limited. Hence, upon
depletion of glucose, S. aureus must derive carbon and nitrogen source from the catabolism of
amino acids such as glutamate, proline, and arginine[3]. These three are the primary
interconvertible carbon source in a glucose depleted environment. Proline, as well as glutamate,
are abundant amino acids within the abscess. In contrast, arginine is depleted at the site of infection
due to inflammatory response and the upregulation of host iNOS and arginase, both requiring
arginine as a substrate. Mutation in the arginine biosynthetic pathway attenuated virulence of S.
aureus in vivo [4, 5]. Therefore, it is important to investigate arginine biosynthesis and its regulation
in S. aureus. Understanding how S. aureus accommodates for arginine depletion in vivo is
important and provides insights on host-pathogen interaction and how the pathogen proliferates
despite the hostile environment.
S. aureus harbors the genes encoding the arginine biosynthetic pathway argJBCDFGH
responsible for synthesizing arginine from glutamate[6]. Biosynthesis of arginine from glutamate
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is a highly conserved and well-characterized pathway adopted by multiple bacteria, including
Bacillus subtilis, Salmonella enterica serovar Typhimurium, and Escherichia coli [7, 8]. However,
studies from Nuxoll et al. documented that in S. aureus arginine is synthesized from proline rather
than glutamate. This study also documented that the arginine biosynthetic pathway is regulated by
carbon catabolite repression (CCR) through the activity of carbon catabolite protein A, CcpA.
Indeed, a ccpA mutant could grow on a media lacking arginine. However, mutations in putA,argG
and argH, but not argC, completely abrogated the growth of the ccpA mutant implicating that the
glutamate pathway is inactive in-vitro[4]. In agreement with the previous observations, Halsey et
al. showed that putA and argGH transcription are upregulated in a ccpA mutant further confirming
that arginine biosynthesis is regulated by CCR and that the production of arginine from proline is
responsible for the phenotype of the ccpA mutant when grown in a media lacking arginine[3].
Hence, based on these studies, one would expect that the growth of S. aureus in media lacking
glucose and arginine (CDM-R) will be induced since CCR and arginine transcription repression
will be alleviated. Surprisingly, S. aureus still exhibits arginine auxotrophy when grown in CDMR. However, growth can be selected after extended incubation. This delayed growth is due to the
selection of mutations in ahrC which encodes for a transcriptional regulator of arginine biosynthetic
genes. In Bacillus subtilis, AhrC exerts regulation through the binding to operator site called ARG
box found upstream of arginine biosynthetic genes mediating their repression in presence of
arginine[9]. Experimental evidence indicates that this mechanism of regulation is conserved among
gram-positive as well as gram-negative bacteria[10, 11]. However, little is known about how AhrC
regulates arginine biosynthesis in S. aureus. This thesis will discuss the importance of proline as
an alternative precursor for arginine biosynthesis and the function of AhrC in regulating arginine
metabolism in S. aureus.
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A historical perspective of arginine biosynthesis: Fundamental change and findings.
Early studies assessing the arginine biosynthesis pathway have brought forth many fundamental
changes in the perspective of scientists regarding the regulation of biochemical pathways. Crucial
experiments were conducted, which contributed to significant knowledge in the field and brought
forward new scientific concepts. In 1953, Henry Vogel observed that arginine is an antagonist for
the enzyme N-acetylornithinase [12]. In 1957, at the McCollum Pratt Symposium, Vogel explained
these data using the term “enzyme repression.” The substance mediating the inhibition was called
the “represser” (spelling now changed to repressor). Since then, the term repressor is an accepted
term in the scientific field as the molecule that inhibits enzyme activity [13]. The experiments
carried out by Werner K. Maas in 1957 demonstrating the kinetics of ornithine
carbamoyltransferase demonstrated that both exogenous and endogenous arginine regulate the rate
of enzyme synthesis in the metabolic pathway [14]. To further elucidate the mechanism behind
enzymatic repression, in 1959, Werner isolated E. coli K12 mutants resistant to canavanine, which
is an arginine analog that competes for protein synthesis. These mutants overcame the inhibition
caused by canavanine and were then derepressed for multiple arginine anabolic enzymes. Werner
had mapped the mutation present in the above mutants and termed the mutated gene as an arginine
repressor (argR). Werner suggested that argR regulates the expression of an “aporepressor” with
arginine acting as the “corepressor” [15, 16]. At the 1961 Cold Spring Harbor Symposium,
Francois Jacob and Jacques Monod documented two important concepts, the operon model and
mRNA [17]. In the same symposium, Werner and Luigi Gorini demonstrated that the arginine
biosynthetic genes are scattered across the chromosome, and yet they are regulated by the same
regulatory element [16-18]. Later in 1964, Werner and John Clark stated that the repressor argR
negatively regulates the arginine biosynthetic genes. Thus, they together coined the term regulon,
which describes the phenomenon where a single regulatory molecule controls a set of unlinked
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genes, as seen in arginine biosynthetic enzymes [19]. These findings have therefore changed the
perspective regarding biochemical regulation and have immensely contributed to the establishment
of the molecular biology field.
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Arginine metabolism and bacterial pathogenesis
S. aureus catabolizes arginine through the highly conserved arginine deiminase (ADI)
pathway. Catabolism of arginine through ADI generates ornithine, ammonia, and carbon dioxide
and 1 ATP. ADI consists of three enzymes encoded on the arc operon: arginine deiminase (ArcA),
ornithine carbamoyltransferase (ArcB), and carbamate kinase (ArcC). Recent evidence
documented that methicillin-resistant community-associated S. aureus (CA-MRSA) has acquired
a second copy of the arc operon found on the arginine catabolic mobile element (ACME) which
was shown to contribute to the ability of this particular strain to thrive within acidic environments
and cause skin and soft tissue infections (SSTI) [20].
Furthermore, arginine serves as a substrate for the NO synthase enzyme (NOS) in S. aureus
resulting in nitric oxide (NO) production. It was demonstrated that NOS functions in hydrogen
peroxide resistance, biofilm formation, and toxin production. Also, evidence has shown that
endogenous nitric oxide mediates S.aureus daptomycin resistance, facilitates nasal colonization,
and promotes protection from oxidative stress [21].
In conclusion, arginine is a part of an extensive metabolic network. It functions in pH
homeostasis, serves as a nitrogen and carbon source and substrate for multiple enzymes all
contributing to the virulence of pathogen within a particular host and affecting S. aureus physiology
and host interactions[22, 23].
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Arginine biosynthesis in Staphylococcus aureus
The arginine biosynthetic pathway from glutamate is a highly conserved and wellcharacterized pathway found among a wide array of bacteria, including Bacillus subtilis,
Salmonella enterica serovar Typhimurium, and Escherichia coli. Genome sequencing has
demonstrated that S. aureus harbors the arginine biosynthetic genes argJBCDFGH; these genes
encode the enzymes responsible for synthesizing arginine from glutamate (Fig.1.1). Although S.
aureus harbors the biosynthetic capability to synthesize arginine, it still exhibits auxotrophy for
arginine when grown on a complex laboratory media. Nuxoll et al. demonstrated that S. aureus
arginine biosynthesis is under carbon catabolite repression and that proline serves as a precursor
for arginine biosynthesis instead of glutamate (Fig.1.2). The highly conserved glutamate pathway
was shown to be inactive under in-vitro conditions. It is still unclear when or if S. aureus
derepresses the glutamate biosynthetic pathway or if there is any niche where this pathway is
activated during host invasion. The enzymes' names participating in arginine biosynthesis along
with their EC number and gene symbol are illustrated in Table.1.1
Further, S. aureus encodes a set of virulence factors that enables it to destroy host tissue
[24]. Among these, SspB and SspA, are proteases that degrade collagen, a proline-rich protein
found in animals [25-28]. Degradation of collagen results in the release of free proline, which can
be used as a substrate for arginine production. Thus, this mechanism adopted by S. aureus might
be beneficial; since collagen is an abundant protein surrounding the fibrotic wall of a
staphylococcal abscess and its use to produce arginine exhibits that S. aureus metabolically adapts
and evolves to acquire nutrients that are readily available at the site of infection to support its
growth.
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Figure 1.1 Arginine Biosynthesis via Glutamate
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Figure 1.2 Arginine biosynthesis via urea cycle in S. aureus.
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Table 1.1 Enzyme name with the corresponding EC number and their gene symbol.

Enzyme Name
Glutamate N-acetyltransferase/aminoacid acetyltransferase
N-Acetylglutamate kinase
N-Acetylglutamylphosphate reductase

EC number
EC:2.3.1.35 2.3.1.1

Gene symbol
argJ

EC 2.7.2.8
EC 1.2.1.38

argB
argC

N-Acetylornithine aminotransferase

EC 2.6.1.11

argD

Ornithine carbamoyltransferase
Argininosuccinate synthetase

EC:2.1.3.3
EC 6.3.4.5

arcB1,arcB2,argF
argG

Argininosuccinase
Arginase
Proline dehydrogenase

EC 4.3.2.1
EC:3.5.3.1
EC:1.5.5.2

argH
rocF
putA
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Regulation of arginine biosynthesis in Staphylococcus aureus.
Transcriptional regulation of arginine biosynthesis was first studied in Escherichia coli where it
was disclosed that ArgR, an L-arginine dependent repressor, represses transcription of arginine
biosynthetic genes by binding to the DNA operator sites found upstream of the arg genes,
overlapping the promoter sequence. Each operator site, known as an ARG box, consists of a pair
of 18 bp palindromic sequences (separated by 2-3 bp) [10, 27]. In Bacillus subtilis, AhrC, an ArgR
homologue, also represses the arginine biosynthetic pathway in presence of arginine, but in contrast
to the mechanism of regulation in E. coli, additional transcriptional activation of arginine catabolic
genes is mediated by AhrC[9]. AhrC forms a hexamer, a dimer of trimers, through oligomerization
of its C-terminal domain. The dimer-trimer interface results in the formation of the arginine binding
pocket consisting of Gln104, Asp111, Thr121, Cys123, Asp125, and Asp126. The N-terminal
domain has a DNA binding motif, this motif was shown to be part of the winged helix-turn-helix
family (wHTH). In the presence of arginine, AhrC binds to the operator sequence, known as ARG
box, located within the promoter of argC and argG, repressing the transcription of the arginine
biosynthetic genes[9].
S.aureus encodes three ArgR-type transcriptional regulators, ArgR1 and ArgR2, and AhrC. ArgR1
and ArgR2 are encoded by argR1 and argR2 genes, respectively. argR1 belongs to the native ADI
operon while argR2 is a monocistronic unit of the second ADI operon encoded by the acquired
arginine catabolic mobile element (ACME). ahrC is co-transcribed with the DNA recombination
gene, recN, both found in the same operon on the chromosome[28]. Halsey et. al demonstrated that
ArgrR1 activates the transcription of putA when carbon catabolite repression is alleviated while
AhrC represses the transcription of rocA and rocD. These data together suggest that both ArgR1
and AhrC regulate arginine biosynthesis via proline. However, unlike other bacteria, where the
regulation of arginine biosynthesis is extensively studied and well-characterized, little is known
how S. aureus transcriptionally regulates arginine biosynthesis. As previously mentioned, S. aureus
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has adopted a novel proline catabolic pathway to synthesize arginine instead of using the glutamate
canonical pathway. Also, S. aureus harbors three transcriptional regulators instead of one, imposing
limitations in studying the regulation of the arginine biosynthetic pathway. Despite the conservation
of the mechanism of regulation among different species, S.aureus appears to regulate arginine
biosynthesis differently, therefore, more studies are needed to investigate how S.aureus functions
to regulate arginine biosynthesis in the case of arginine starvation.
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2. Chapter 2: Materials and Methods

Bacterial strains and culture Conditions
All strains used in this study are listed in Table. 2.1. Defined bursa aurealis transposon mutants
were obtained from the Nebraska Transposon Mutant Library and backcrossed to JE2 using
Ф11[29]. JE2 ahrC markless deletion mutant ΔahrC was generated as described in[3].JE2 ahrC
mutant was isolated after 18-24 hours growth of JE2 in complete defined media lacking arginine
(CDM-R). Following the delayed growth on CDM-R, colonies were selected on Tryptic Soy Agar
(TSA) and growth was assessed in CDM-R. The colonies that exhibited growth in CDM-R were
sent for whole-genome sequencing. Whole-genome sequencing results are illustrated in Table 2.1
Bacterial cultures were grown overnight in 5 mL Tryptic Soy Broth at 37°C with shaking at 250
rpm. Overnight cultures were washed with phosphate-buffered saline (PBS) and inoculated to an
optical density at 600 nm (OD600) of 0.05. Growth curves were performed in CDM and CDM-R
with no glucose added[30] in 96-well plate in the Tecan Device at 37°C with shaking at 250 rpm.

RNA isolation and RT-qPCR analysis
Cultures of S. aureus JE2, JE2 ahrC and ΔahrC were grown overnight in 3ml CDM at 37°C with
shaking at 250 rpm. Overnight cultures were inoculated to an OD600 of 0.05 into 25 ml of CDM or
CDM-R into 250 mL flask (1:10 volume to flask ratio). Cells were grown to exponential phase and
were collected when they reach an OD600 = 0.4-0.8. 6 mL of Qiagen RNAprotect Bacteria reagent
was added to 3 mL of collected culture. Following, Cells were incubated for 5 minutes at room
temperature, pelleted by centrifugation for 10 minutes at full speed. Pellet was resuspended in 185
uL lysis buffer, followed by 15 uL of proteinase K. Next, samples were incubated at rotating
platform shaker at room temperature for 10 min then resuspended in 700 uL RLT buffer with 1%
-mercaptoethanol. Suspensions were transferred to lysing matrix B tubes (MP Biomedicals) and

13
processed in an FP120 FastPrep cell disrupter (MP Biomedicals) for 45 seconds at a setting of 6.0.
760 uL of the supernatant was transferred into a new tube containing 590 uL of 80% ethanol. The
samples were then processed using an RNeasy mini kit, according to manufactures instructions
(Qiagen, Inc.). cDNA was generated using SuperScript™ IV VILO™ Master Mix with
ezDNase™ Enzyme with 1 pg to 2.5 µg total RNA in each 10 uL reaction.
All qPCRs were performed in 20μl reactions (10μl Taq DNA polymerase MasterMix
(ThermoFisher), 1μl of 10μM primer sets, 4μl H2O, 5μl template cDNA). Standards and samples
were assayed in duplicate in the LightCycler©480 device. All primer-probe set used are listed in
Table. 2.3 and 2.4

Liquid Chromatography with tandem mass spectrometry (LC-MS/MS).
LC-MS/MS separation and quantitation were carried out using XBridge Amide 3.5 µm (2.1 x 100
mm) column procured from Waters. Mobile phase A was 10 mM ammonium acetate and 10 mM
ammonium hydroxide in water + 5% acetonitrile whereas mobile phase B contains 100%
acetonitrile. The flow rate was 0.4mL/min with a gradient mode of mobile phases. The column was
maintained at 40 ℃. Detection of metabolites was carried out using QTRAP 6500 (Sciex) in
multiple reaction mode (MRM). All the labeled metabolites such as canonical and non-canonical
amino acid standard mixtures, 13C-arginine, 13C-glutamate and 13C-proline were purchased from
Cambridge Isotopes Inc, USA.

Transduction of putA:: NΣ, argH:: NΣ and argC:: NΣ into JE2 ahrC mutant and
ΔahrC background.
Ф11 transducing lysates were prepared from defined JE2 bursa aurealis mutants with insertions in
the putA, argH, argC. These bursa aurealis mutations conferring erythromycin resistance were
transduced into JE2 ahrC and ΔahrC. Mutants were selected on TSA containing 10 μg/ml
erythromycin. Subsequently, Insertions of putA,argH and argC were confirmed by PCR.
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Table 2.1 Bacterial Strains used in this study
Bacterial Strains
S. aureus JE2
S. aureus putA:: NΣ
S. aureus argH:: NΣ
S. aureus argC:: NΣ
JE2 ahrC mutant
ΔahrC
S. aureus JE2
argR1::ΝΣ
S. aureus JE2
argR2:: ΝΣ

Phenotypes
LAC cured of all 3 native plasmids
bursa aurealis mutation in proline
dehydrogenase
bursa aurealis mutation argininosuccinase
bursa aurealis mutation acetylglutamylphosphate
reductase
Mutant selected after extended growth in CDMR
Markerless deletion in SAUS200_1469,
arginine repressor
bursa aurealis mutation in
SAUSA300_2571, arginine repressor
bursa aurealis mutation in
SAUSA300_0066, arginine repressor

Source
[29]
[29]
[29]
[29]
This study
[3]
[3]
[3]
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Table 2.2 Whole Genome Sequencig results

Isolate

Start

Change

1

146215

C -> A

1

963762

T -> C

1

1655458

C -> A

1

2524007

G -> T

1
2
2
4
4
8
8
17

2784181
1358107
2784181
447901
2784181
2784202
2784204
1639590

A -> G
A -> C
A -> G
C -> T
A -> G
A -> T
-A
C -> A

18

804659

18

Amino
Acid
Change
L -> S

Protein
Effect

Product

Truncation

FIG01107877:
hypothetical protein
ATP-dependent
nuclease, subunit B
Late competence
protein ComGF,
access of DNA to
ComEA, FIG017774
Nitrite reductase
[NAD(P)H] large
subunit (EC 1.7.1.4)
Arc promoter

Substitution
Truncation

P -> T

Substitution

H -> Y

Substitution

C -> F

Substitution

A -> T

L -> I

Substitution

1564471

C -> T

G -> D

Substitution

18
18
21

2711153
2784204
1550253

T -> G
A -> T
C -> A

I -> L

Substitution

P -> H

Substitution

21
21

1561036
1639949

T -> A
T -> A

K -> N

Substitution

22

304912

G -> A

A -> T

Substitution

22

505342

CGG ->
TTT

GG -> GL

Substitution

22

1034607

G -> T

Arc promoter
Exotoxin 7
Arc promoter
Arc promoter
Arc promoter
AhrC, repressor of arg
regulon
Di/tripeptide permease
YjdL
Phage lysin, Nacetylmuramoyl-Lalanine amidase (EC
3.5.1.28)
Acyltransferase
Arc promoter
L-asparaginase (EC
3.5.1.1)
Arginine pathway
regulatory protein
AhrC, repressor of arg
regulon
Glycosyl transferase
family protein,
putative
PTS system,
trehalose-specific IIB
component
(EC2.7.1.69)

16
22

1721293

C -> A

V -> L

Substitution

22
24

2784215
1427979

A -> T
A -> G

I -> V

Substitution

24

2513697

G -> A

P -> L

Substitution

24

2784181

A -> G

peptidase, U32 family
small subunit [C1]
Arc promoter
Mobile element
protein
Two component
sensor histidine kinase
Arc promoter
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Table 2.3 Oligonucleotides used in the RT-qPCR study

Name

Sequence

Comments

oLH1

CCT TAT GGC GAT GAT TGG
TTT G

Forward primer for S. aureus JE2 putA
transcriptional analysis by RT-PCR

oLH2

CCA GCA GGT TTC ACA
AAT TCT T

Reverse primer for S. aureus JE2 putA
transcriptional analysis by RT-PCR

oLH3

GGT CTT GGT AGA ACT
GGG AAA T

Forward primer for S. aureus JE2 rocD
(SAUSA300_0187) transcriptional analysis by
RT-PCR

oLH4

CAA GTA CAG CAG ATA
CAG GGT ATA A

Reverse primer for S. aureus JE2 rocD
(SAUSA300_0187) transcriptional analysis by
RT-PCR

oLH5

CTG TAG AGG ATA CTG
CGA AAG T

Forward primer for S. aureus JE2 arcB1
transcriptional analysis by RT-PCR

oLH6

GGA TGC CAA TCG TCT GTT
AAT C

Reverse primer for S. aureus JE2 arcB1
transcriptional analysis by RT-PCR

oLH7

CAT TTG AAA CAG CGG
CTT ATG A

Forward primer for S. aureus JE2 arcB2
transcriptional analysis by RT-PCR

oLH8

ACA CGA GCA GTA TCT
TTG GTA G

Reverse primer for S. aureus JE2 arcB2
transcriptional analysis by RT-PCR

oLH9

AAG AAC GCG ATG TGC
ATT TG

Forward primer for S. aureus JE2 argF
transcriptional analysis by RT-PCR

oLH10 AGC ACA CGT GCA GTA
TCT TTA

Reverse primer for S. aureus JE2 argF
transcriptional analysis by RT-PCR

oLH11 CAG AGC GAA TGA ATG
TGG TAT TT

Forward primer for S. aureus JE2 argGH
transcriptional analysis by RT-PCR

oLH12 TCA GCA GTA TCT GGT GTT
TCT T

Reverse primer for S. aureus JE2 argGH
transcriptional analysis by RT-PCR

oLH13 CGG TAG GTT CAG TAT
CAG CAA TAA

Forward primer for S. aureus JE2 rocF
transcriptional analysis by RT-PCR

oLH14 TTT CCA CTT GGT GAC TCT
TCA G

Reverse primer for S. aureus JE2 rocF
transcriptional analysis by RT-PCR
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oLH15 ATG TCT TTA CAC CTG GCT
CAC

Forward primer for S. aureus JE2 rocD
(SAUSA300_0860) transcriptional analysis by
RT-PCR

oLH16 GGC CTG GTA AAT CCT CAT
CAA

Reverse primer for S. aureus JE2 rocD
(SAUSA300_0860) transcriptional analysis by
RT-PCR

oLH17 CAA ATG ATC ACA GCA
TTT GGT ACA G

Forward primer for S. aureus JE2 gyrB
(SAUSA300_0005) transcriptional analysis by
RT-PCR. Primer sequence taken from Borgogna
2018 J Infect Dis. Adenine residue in bold was
not present in primer sequence listed in the
publication.

oLH18 CGG CAT CAG TCA TAA
TGA CGA T

Reverse primer for S. aureus JE2 gyrB
(SAUSA300_0005) transcriptional analysis by
RT-PCR. Primer sequence taken from Borgogna
2018 J Infect Dis.

oLH19 GAA GAG CGT GAA AGT
GGT AAA G

Forward primer for detection of tpiA transcript by
qPCR

oLH20 GAT TGC CCA GAT TGG TTC
ATA AG

Reverse primer for detection of tpiA transcript by
qPCR
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Table 2.4 Probes used in the RT-qPCR study.
Name

Sequence

5'
modification

3'
modification

Primer pair

Comments

prLH1

TGA GAA
GAT TAG
CAG AAC
GCC CAC
A

6-FAM

BHQ-1

oLH1/oLH2

Taqman probe for
detection of putA
transcript by qPCR

prLH2

ATG GAA
TGG GAG
CAA GTC
GTT CCA

HEX

BHQ-1

oLH3/oLH4

Taqman probe for
detection of rocD
(SAUSA300_0187)
transcript by qPCR

prLH3

CAC CGG
TAC ACC
AGA
GAA CTT
CGC

6-FAM

BHQ-1

oLH5/oLH6

Taqman probe for
detection of arcB1
transcript by qPCR

prLH4

TAC CCA
TTT GAG
AAC CTG
TTG GCC
C

HEX

BHQ-1

oLH7/oLH8

Taqman probe for
detection of arcB2
transcript by qPCR

prLH5

AAG TTG
CAG CGC
ATG ATC
AAG GTG

6-FAM

BHQ-1

oLH9/oLH10

Taqman probe for
detection of argF
transcript by qPCR

prLH6

AGA
AGA TCC
TTA TGC
TGC GCC
ACC

HEX

BHQ-1

oLH11/oLH12 Taqman probe for
detection of argGH
transcript by qPCR

prLH7

AGG TGT
TAT TTG
GTA TGA
TGC ACA
TGG TGA

6-FAM

BHQ-1

oLH13/oLH14 Taqman probe for
detection of rocF
transcript by qPCR
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prLH8

TGG TAA
TCC ACT
TGC TTG
TGC TGC

HEX

BHQ-1

oLH15/oLH16 Taqman probe for
detection of rocD
(SAUSA300_0860)
transcript by qPCR

prLH9

AAT CGG
TGG CGA
CTT TGA
TCT AGC
GAA AG

6-FAM

BHQ-1

oLH17/oLH18 Taqman probe for
detection of gyrB
transcript by
qPCR. Probe sequence
was taken from
Borgogna 2018 J
Infect Dis.

HEX

BHQ-1

oLH19/oLH20 Probe for detection of
tpiA transcript by
qPCR

prLH10 CCT GCA
ACA GCT
TTC TTA
ACT TGC
TCA C
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3. Chapter 3: Results

Staphylococcus aureus is a functional arginine auxotroph
Based on the study by Nuxoll et al., the growth of S. aureus in media lacking arginine can
be observed when glucose is not supplemented in the media. Complicating the picture, the growth
of S. aureus was not observed when grown in a complete defined media lacking arginine without
glucose (CDM-R) (Fig.3.1 A). However, upon extended incubation, we found that growth is
consistently observed after 18-24 hours of growth. To test if this phenomenon is due to the potential
induction of a particular metabolic pathway or selection of mutations, we streaked the colonies on
Tryptic Soy Agar (TSA) following delayed growth on CDM-R and the growth pattern was tested
in CDM-R.These colonies can rapidly grow on CDM-R (Fig.3.1 B) suggesting that S. aureus is a
functional arginine auxotroph unless suppressor mutations facilitate the growth of this strain when
exogenous arginine is not supplemented in the media.
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Figure 3.1 Suppressor mutations facilitate the growth of S. aureus in CDM-R. Growth
analysis of JE2 in (CDM) and (CDM-R). B. Growth analysis of JE2 suppressor mutant in (CDMR). Data represents means ± SEM of three biological replicates.
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S. aureus arcB1 and ahrC mutations facilitate growth in CDM-R.
Whole Genome Sequencing (WGS) of suppressors mutants identified two classes of mutations in
the isolated colonies. Four isolates have mutations in the promoter region of the arcA1B1DC.
Interestingly, two isolates have mutations in the Arginine pathway regulatory protein, AhrC. One
of the isolates has a substitution mutation changing cysteine (Cys123) into phenylalanine (Fig.3.2).
This cysteine residue is found at the dimer-trimer interface participating in the formation of an
arginine binding pocket. Therefore, since AhrC was reported to be an L-arginine dependent
repressor, this mutation will hinder the ability of AhrC to mediate repression of the arginine
biosynthetic genes thus enabling the growth of S. aureus in complete defined media lacking
arginine. The focus of this study will be on the ahrC isolate which will be referred to as the JE2
ahrC mutant
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Figure 3.2 JE2 suppressor mutation in the Arginine pathway regulatory protein, AhrC.
Alignment of AhrC of the JE2 suppressor mutant against AhrC of wild type JE2.The alignment
was done using VectorNTI align-X. Note the change of the cysteine into phenylalanine.
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AhrC is the major regulator of arginine biosynthesis in S. aureus
To confirm the growth observed in the JE2 ahrC mutant, growth analysis of ahrC markless deletion
JE2 ΔahrC was performed. JE2 ΔahrC exhibits the same phenotype as JE2 ahrC mutant when
grown in CDM-R confirming that the ahrC mutation facilitates the growth of S.aureus in the
absence of extracellular arginine. Besides, since S. aureus encodes three ArgR-type transcriptional
regulators, ArgR1 and ArgR2, and AhrC, to eliminate the possibility that ArgR1 and ArgR2 are
complementing AhrC function, growth of JE2 argR1:: NΣ and JE2 argR2:: NΣ was assessed in
CDM-R. argR1:: NΣ does not grow in CDM-R and argR2:: NΣ exhibits a delayed growth reaching

OD600 after 24 hours (Fig.3.3). Taken together, these data suggest that these three transcriptional
regulators do not complement each other and that AhrC is the main repressor of arginine
biosynthesis.
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Figure 3.3 Mutation in argR1 and agrR2 does not facilitate S. aureus growth in CDM-R.
Growth curve analysis of argR1:: NΣ, argR2:: NΣ and ΔahrC in CDM-R. Data represents means
± SEM of three biological replicates.
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Arginine biosynthesis is dependent upon proline in ahrC mutants
S. aureus harbors the novel proline catabolic pathway as well as the canonical glutamate
pathway to synthesize arginine. To investigate which metabolic pathway contributed to the growth
of both the JE2 ahrC mutant and ΔahrC in CDM-R, transduction of putA, argC and argH was
performed. The growth of the resulting mutants was evaluated in CDM-R. Mutation of putA and
argH halted the growth of the JE2 ahrC mutant as well as ΔahrC. However, the mutation in argC
did not affect the growth (Fig.3.4) To confirm these results, the JE2 ahrC mutant was grown in
CDM-R in the presence of either 13C5-Pro or 13C5-Glu. 13C5-labelled arginine was detected in the
presence of proline and not glutamate (Fig.3.5). These data strongly suggest that S. aureus relies
on proline as a precursor to synthesize arginine and that unlike AhrC in Bacillus subtilis, AhrC in
S. aureus appears to regulate arginine biosynthesis via proline with no repression being exerted on
the argDCJB operon.
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Figure 3.4 Proline catabolism facilitates growth ahrC mutants in CDM-R.Growth curves
analysis of ΔahrC/putA::NΣ,ΔahrC/argC:: NΣ , ΔahrC/argH:: NΣ, JE2 ahrC mutant/ putA::NΣ,JE2
ahrC mutant/ argC:: NΣ, JE2 ahrC mutant/ argH:: NΣ in CDM-R. Data represents means ± SEM
of three biological replicates.
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Figure 3.5 Growth JE2 ahrC mutant is dependent upon arginine biosynthesis via proline.
Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) of JE2 ahrC mutant grown
in CDM-R in the presence of either 13C5-Proline or 13C5-Glutamate.Data represent active peaks
out of three biological replicates are displayed
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AhrC functions to repress argGH and arcB1 in the absence of extracellular arginine.
To investigate how AhrC regulates arginine biosynthesis in S.aureus, quantitative reverse
transcription (RT-qPCR) was performed to assess the transcription of arginine biosynthetic genes
in the JE2 ahrC mutant and ΔahrC when grown in CDM and CDM-R compared to wild type JE2
in CDM. Transcription of putA ,argD ,arcB1 ,arcB2 ,arg F,argG ,rocF, rocD were assessed. A
significant change in the gene expression of argG and arcB1 was observed with approximately
3000 and 100 fold change, respectively, in ΔahrC when grown in CDM-R compared to wild type
JE2 in CDM (Fig.3.6). Similar results were observed in the JE2 ahrC mutant with no change of
argDCJB gene expression in both ΔahrC and JE2 ahrC mutant. Therefore, the transcription
analysis results demonstrate that in S. aureus, AhrC functions to repress argGH and arcB1 in
absence of arginine allowing for arginine biosynthesis via proline. Indeed, as stated above, growth
in CDM-R via an ahrC mutation is proline-dependent and glutamate-independent. In addition, our
LC-MS/MS demonstrated the accumulation of
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C5-ornithine and 13C5-citrulline in the presence of
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C5-proline and not glutamate (Fig. 3.7). ArcB1 catalyzes the formation of citrulline by using

ornithine as a substrate whereas citrulline is subsequently converted into arginine through the
activity of ArgG and ArgH, further confirming our transcriptional data as well as that argGH and
arcB1 facilitate the biosynthesis of arginine via proline.
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Figure 3.6 ahrC mutation augments argGH and arcB1 transcription allowing for arginine
biosynthesis via proline. Quantitative reverse transcription PCR (RT-qPCR) assessing the
expression of arginine biosynthesis genes in ΔahrC and JE2 ahrC mutant. A) Relative expression
of argG, a transcriptional unit representing argGH operon, in both CDM and CDM-R. B) Relative
expression of arcB1, a transcriptional unit representing arcA1B1DC operon, in both CDM and
CDM-R.
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Figure 3.7 ArcB1, ArgG, ArgH catalyzes the formation of arginine from proline. Liquid
Chromatography with tandem mass spectrometry (LC-MS-MS) of JE2 ahrC mutant grown in
CDM-R in the presence of either 13C5-Proline or 13C5-Glutamate.Accumulation of both A) ornithine
and B) citrulline was detected in the presence of 13C5-Proline. Representative date from three
biological replicates.
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4. Chapter 4: Discussion
Historically, the extensive studies of the arginine biosynthetic pathway have led to the
disclosure of multiple findings, which has set the basic features of metabolic regulation and brought
forth numerous scientific notions such as repression, repressor, and regulon [12, 13, 31].
Publications identifying enzymes and genes which are necessary for arginine biosynthesis have
brought insights of evolutionary significance [6]. The study on the arg regulon has led to multiple
discoveries including gene duplication, the mechanism involved in the reactivation of silent genes
through the generation of tandem repeats, and the precise function of a transposon as a mobile
promoter as well as the origin of divergent promoters [32-35].
Despite harboring the biosynthetic capability to synthesize arginine, S. aureus exhibits
auxotrophy for arginine when grown on a defined laboratory media lacking arginine [36]. We
demonstrated that growth in media lacking arginine can be selected after extended incubation. We
have shown that this delayed growth is due to the selection of mutations in ahrC loci. AhrC is a
transcriptional regulator that represses arginine biosynthesis when arginine is present by binding to
an operator site called the ARG box found upstream of arginine biosynthetic genes
(argJBCDFGH). Experimental evidence indicates that this mechanism of regulation is conserved
among gram-positive as well as gram-negative bacteria. our data provided evidence that AhrC in
S. aureus regulates arginine biosynthesis via proline and not glutamate. Indeed, mutations in putA
and argH have completely abrogated the growth of JE2 ahrC mutant as well as ΔahrC in CDM-R
while a mutation in argC did not affect the growth. Furthermore, our LC-MS/MS demonstrated the
accumulation of 13C5-arginine when the JE2 ahrC mutant was grown in CDM-R in the presence
of 13C5-proline and not 13C5-glutamate further confirming that AhrC functions to regulate arginine
biosynthesis via proline and not glutamate. Also, our transcriptional analysis revealed that AhrC
represses argGH and arcB1 with no change in gene expression of argDCJB. Our LC-MS/MS
analysis supports these data with the accumulation of ornithine and citrulline was observed in the
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presence of 13C5-proline suggesting that proline is being catabolized into arginine by the enzymatic
activity of arcB1, argG and argH. These data together suggest that AhrC functions to repress
argGH transcription allowing for arginine biosynthesis via proline. These data also suggest the
presence of an additional transcriptional regulator functioning to repress the production of arginine
from glutamate. Further, results from our laboratory demonstrate that a putA mutant does not grow
in defined media lacking arginine indicating that the glutamate pathway is inactive in vitro.
However, the selection of putA suppressor mutants that can grow in a media lacking arginine has
allowed us to identify that the glutamate pathway is induced when SpoVG, a DNA binding protein
is mutated (data not shown). However, it is still unknown how SpoVG regulates arginine
biosynthesis and why S. aureus has adopted a novel pathway via proline for arginine biosynthesis.
Using proline as a precursor suggests that S. aureus is maintaining the glutamate pool to be used
by other biosynthetic pathways. It is well documented that glutamate is an important precursor to
produce siderophores. Siderophores are iron scavenging proteins secreted by S. aureus to overcome
the iron limitation. S. aureus harbors two siderophores, Staphyloferrin A (SA) and Staphyloferrin
B (SB). SA production relies on TCA cycle activity, however, interestingly, SB production is
independent of TCA cycle activity and all its precursors are generated through the metabolism of
glutamate. This independence from the TCA cycle highlights the importance of glutamate in the
production of staphyloferrin B, which was shown to be more important in vivo than the other
siderophores [37]. Iron sequestration from the host contributes to S. aureus virulence and its ability
to cause severe and invasive infection. Hence, the exploitation of glutamate by the arginine
biosynthetic pathway may come at a cost, making S. aureus less virulent and attenuated for
pathogenesis.
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5. Chapter 5: Concluding Remarks and Future Directions.

S. aureus can invade multiple organ systems causing infection in diverse metabolic
environments. To survive and proliferate within the host, S. aureus has evolved to fine-tune its
metabolism to utilize carbon sources unique to each niche. Several studies have been conducted on
S. aureus metabolism, however, little emphasis has been given on how arginine metabolism
facilitates the proliferation of this organism during infection. Investigating important metabolic
pathways is crucial and leads to the development of therapeutic that disrupts critical metabolic
pathways and limits the growth of this highly adaptable pathogen.
It has been known for decades that S. aureus is auxotrophic for many amino acids including
arginine. We identified that after extended incubation, S. aureus can be trained to grow in a defined
media lacking arginine via the selection of mutations. We have also demonstrated that arginine
biosynthesis via proline is under repression, with AhrC repressing argGH and arcB1. Interestingly,
the selected mutants still do not synthesize arginine via glutamate. However, using a mutant unable
to synthesize arginine via proline, we identified mutants able to synthesize arginine via glutamate.
Through the selection of suppressors mutants, we identified SpoVG as a potential transcriptional
regulator of glutamate-mediated arginine biosynthesis. In the future study, we will determine how
SpoVG regulates arginine biosynthesis and if SpoVG interacts with AhrC to mediate effective and
strong regulation. In addition, the biosynthesis of arginine via glutamate is tightly regulated in S.
aureus. It is unclear when or if S. aureus derepresses the glutamate biosynthetic pathway during
host invasion. In our future study, we will also determine the impact of the induction of the
glutamate pathway on the ability of S. aureus to colonize and survive within different niches. The
generated data will provide insight into whether the differential regulation selected within S. aureus
is beneficial or if it negatively impacts other metabolic strategies employed by S. aureus to thrive
in nutrient-limited environments.
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In conclusion, S. aureus appears to regulate the arginine biosynthetic pathway differently.
How this regulation of biosynthetic pathway impacts S. aureus virulence and persistence has not
been determined to date. Therefore, further studies are required to understand how metabolic
regulation is intricately associated with the ability of S. aureus to survive within a hostile
environment and how S.aureus tailors niche-specific biosynthesis regulation by modulating the
function of transcriptional regulators.
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